share_log

贝瑞基因(000710.SZ):前三季度净利润1038.55万元,同比增长107.70%

Berry Genomics (000710.SZ): The net income for the first three quarters was 10.3855 million yuan, an increase of 107.70% year-on-year.

Gelonghui Finance ·  Oct 28, 2024 17:51

On October 28th, Gelonhui announced Berry Genomics' (000710.SZ) third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.823 billion yuan, a decrease of 4.96% year-on-year; net income attributable to shareholders of the listed company was 10.3855 million yuan, an increase of 107.70% year-on-year; net income after deducting non-recurring gains and losses was 12.8122 million yuan, an increase of 111.17% year-on-year; basic earnings per share were 0.0294 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment